TY - JOUR
T1 - The International Sexual Health And Reproductive Health Survey (I-SHARE-1)
T2 - A Multi-Country Analysis of Adults from 30 Countries Prior to and During the Initial COVID-19 Wave
AU - Erausquin, Jennifer Toller
AU - Tan, Rayner K J
AU - Uhlich, Maximiliane
AU - Francis, Joel M
AU - Kumar, Navin
AU - Campbell, Linda
AU - Zhang, Wei-Hong
AU - Hlatshwako, Takhona G
AU - Kosana, Priya
AU - Shah, Sonam
AU - Brenner, Erica M
AU - Remmerie, Lore
AU - Mussa, Aamirah
AU - Klapilova, Katerina
AU - Mark, Kristen
AU - Perotta, Gabriela
AU - Gabster, Amanda
AU - Wouters, Edwin
AU - Burns, Sharyn
AU - Hendriks, Jacqueline
AU - Hensel, Devon J
AU - Shamu, Simukai
AU - Strizzi, Jenna Marie
AU - Esho, Tammary
AU - Morroni, Chelsea
AU - Eleuteri, Stefano
AU - Sahril, Norhafiza
AU - Low, Wah Yun
AU - Plasilova, Leona
AU - Lazdane, Gunta
AU - Marks, Michael
AU - Olumide, Adesola
AU - Abdelhamed, Amr
AU - López Gómez, Alejandra
AU - Michielsen, Kristien
AU - Moreau, Caroline
AU - Tucker, Joseph D
AU - I-SHARE research consortium
N1 - © The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
PY - 2022
Y1 - 2022
N2 - BACKGROUND: There is limited evidence to date about changes to sexual and reproductive health (SRH) during the initial wave of COVID-19 disease. To address this gap, our team organized a multi-country, cross-sectional online survey as part of a global consortium.METHODS: Consortium research teams conducted online surveys in 30 countries. Sampling methods included convenience, online panels, and population-representative. Primary outcomes included sexual behaviors, partner violence, and SRH service utilization, and we compared three months prior to and during policy measures to mitigate COVID-19. We conducted meta-analyses for primary outcomes and graded the certainty of the evidence using Cochrane methods.RESULTS: Among 4546 respondents with casual partners, condom use stayed the same for 3374 (74.4%) people and 640 (14.1%) people reported a decline. Fewer respondents reported physical or sexual partner violence during COVID-19 measures (1063/15144, 7.0%) compared to the period before COVID-19 measures (1469/15887, 9.3%). COVID-19 measures impeded access to condoms (933/10790, 8.7%), contraceptives (610/8175, 7.5%), and HIV/STI testing (750/1965, 30.7%). Pooled estimates from meta-analysis indicate during COVID-19 measures, 32.3% (95% CI 23.9-42.1) of people needing HIV/STI testing had hindered access, 4.4% (95% CI 3.4-5.4) experienced partner violence, and 5.8% (95% CI 5.4-8.2) decreased casual partner condom use (moderate certainty of evidence for each outcome). Meta-analysis findings were robust in sensitivity analyses that examined country income level, sample size, and sampling strategy.CONCLUSIONS: Open science methods are feasible to organize research studies as part of emergency responses. The initial COVID-19 wave impacted SRH behaviors and access to services across diverse global settings.
AB - BACKGROUND: There is limited evidence to date about changes to sexual and reproductive health (SRH) during the initial wave of COVID-19 disease. To address this gap, our team organized a multi-country, cross-sectional online survey as part of a global consortium.METHODS: Consortium research teams conducted online surveys in 30 countries. Sampling methods included convenience, online panels, and population-representative. Primary outcomes included sexual behaviors, partner violence, and SRH service utilization, and we compared three months prior to and during policy measures to mitigate COVID-19. We conducted meta-analyses for primary outcomes and graded the certainty of the evidence using Cochrane methods.RESULTS: Among 4546 respondents with casual partners, condom use stayed the same for 3374 (74.4%) people and 640 (14.1%) people reported a decline. Fewer respondents reported physical or sexual partner violence during COVID-19 measures (1063/15144, 7.0%) compared to the period before COVID-19 measures (1469/15887, 9.3%). COVID-19 measures impeded access to condoms (933/10790, 8.7%), contraceptives (610/8175, 7.5%), and HIV/STI testing (750/1965, 30.7%). Pooled estimates from meta-analysis indicate during COVID-19 measures, 32.3% (95% CI 23.9-42.1) of people needing HIV/STI testing had hindered access, 4.4% (95% CI 3.4-5.4) experienced partner violence, and 5.8% (95% CI 5.4-8.2) decreased casual partner condom use (moderate certainty of evidence for each outcome). Meta-analysis findings were robust in sensitivity analyses that examined country income level, sample size, and sampling strategy.CONCLUSIONS: Open science methods are feasible to organize research studies as part of emergency responses. The initial COVID-19 wave impacted SRH behaviors and access to services across diverse global settings.
U2 - 10.1093/cid/ciac102
DO - 10.1093/cid/ciac102
M3 - Journal article
C2 - 35136960
SN - 1058-4838
VL - 75
SP - e991–e999
JO - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
IS - 1
ER -